Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GX Pharma is a China-based contract research organization focused on pharmaceutical R&D, clinical research, and regulatory submission support for drugs, biologics, and medical devices. The company provides integrated services spanning clinical trial design and operations, registration and declaration, data management and biostatistics, pharmacovigilance, post-marketing studies, and bioequivalence-related work. GX Pharma has also expanded into specialty areas including rare diseases and cell therapy-related services, positioning itself as a broader life sciences service platform rather than a single-asset drug developer. It appears to operate primarily as a service company rather than as a therapeutics company with a disclosed proprietary clinical pipeline. The business is private and headquartered in Beijing, with a broader office network in China and some overseas presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GX Pharma.